Postby Egypt » Tue Feb 19, 2013 10:32 am
Female genital mutation in Africa:
Burkina Faso (73% prevalence, Type II)
Cameroon (20% prevalence, Type I and II)
Central African Republic (43.4% prevalence, Type I and II)
Côte d'Ivoire (44.5% prevalence, Type II)
Gambia (80–90% prevalence, Type I, II, III and IV)
Ghana (40% prevalence, Type I, II and III)
Guinea-Bissau (50% prevalence)
Kenya (50% prevalence, Type I, II and III)
Liberia (60% prevalence, Type II)
Malawi
Mali (92% prevalence, Type I, II and III)
Mauritania (71% prevalence, Type I and II)
Mozambique (No Data)
Niger (20% prevalence, Type II)
Nigeria (25.1% prevalence, Type I, II and III)
Republic of the Congo (5% prevalence, Type II)
Senegal (20–30% prevalence, Type II and III)
Sierra Leone (90% prevalence, Type II)
Sudan (91% prevalence, Type I, II and III)
Tanzania (17.6% prevalence, Type II and III)
Uganda (<5% prevalence, Type I and II)
Zaire (5% prevalence)
Zimbabwe